Engineered Dex: A promising therapeutic strategy for oral squamous cell carcinoma
- PMID: 36058533
- DOI: 10.1016/j.jormas.2022.08.020
Engineered Dex: A promising therapeutic strategy for oral squamous cell carcinoma
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical